
|Slideshows|August 4, 2019
Brain Health in Aging Adults
Author(s)Mark L. Fuerst
Three studies highlight sedentary behavior and memory, cognitive decline in psychosis, and risk of dementia with anticholinergic drugs.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation
2
Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease
3
Future DSM Plans Overlook Core Problem of Validity
4
Classic Drug, New Target: Lithium as Disease-Modifying in Alzheimer Dementia
5









